Vanguard Investments Australia
ANIP icon

Vanguard Investments Australia’s ANI Pharmaceuticals ANIP Stock Holding History

Vanguard Investments Australia’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$370K Hold
4,472
– – ﹤0.01% 1800
2026
Q1 		$344K Buy
+4,472
New +$349K ﹤0.01% 1772

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Investments Australia's ANIP Position: Q2 2026 in Review

Vanguard Investments Australia held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 4,472 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

Vanguard Investments Australia first reported a position in ANIP in Q1 2026 and has held it in 2 quarters since. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Vanguard Investments Australia held 4,472 shares of ANI Pharmaceuticals worth $370K as of Q2 2026.
  • Vanguard Investments Australia left its ANI Pharmaceuticals share count unchanged in Q2 2026.
  • ANI Pharmaceuticals made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1800 holding.
  • Vanguard Investments Australia first reported a position in ANI Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.